Nephros (NEPH) Revenue Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.76% |
| Dec 31, 2025 | 15.17% |
| Sep 30, 2025 | 17.57% |
| Jun 30, 2025 | 22.88% |
| Mar 31, 2025 | 14.04% |
| Dec 31, 2024 | 4.13% |
| Sep 30, 2024 | 2.60% |
| Jun 30, 2024 | 7.09% |
| Mar 31, 2024 | 14.77% |
| Dec 31, 2023 | 15.08% |
| Sep 30, 2023 | 16.77% |
| Jun 30, 2023 | 21.01% |
| Mar 31, 2023 | 30.28% |
| Dec 31, 2022 | 14.50% |
| Sep 30, 2022 | 21.34% |
| Jun 30, 2022 | 27.11% |
| Mar 31, 2022 | 25.63% |
| Dec 31, 2021 | 29.50% |
| Sep 30, 2021 | 44.66% |
| Jun 30, 2021 | 34.81% |
| Mar 31, 2021 | 38.08% |
| Dec 31, 2020 | 45.57% |
| Sep 30, 2020 | 45.97% |
| Jun 30, 2020 | 22.70% |
| Mar 31, 2020 | 36.84% |
| Dec 31, 2019 | 56.01% |
| Sep 30, 2019 | 59.69% |
| Jun 30, 2019 | 39.25% |
| Mar 31, 2019 | 30.19% |
| Dec 31, 2018 | 32.69% |
| Sep 30, 2018 | 32.76% |
| Jun 30, 2018 | 18.89% |
| Mar 31, 2018 | 13.58% |
| Dec 31, 2017 | 8.19% |
| Sep 30, 2017 | 15.90% |
| Jun 30, 2017 | 23.25% |
| Mar 31, 2017 | 13.90% |
| Dec 31, 2016 | 1.96% |
| Sep 30, 2016 | 13.09% |
| Jun 30, 2016 | -4.39% |
| Mar 31, 2016 | -4.36% |
| Dec 31, 2015 | -7.14% |
| Sep 30, 2015 | -12.45% |
| Jun 30, 2015 | -6.86% |